Economic Survey Emphasizes Budget 2026's Importance for the Pharmaceutical Industry
Thursday, 29 January 2026, 01:48
Economic Survey Insights on Budget 2026
The Economic Survey of 2025-26 shed light on the profound impact of budget 2026 on the pharmaceutical industry. As the industry adapts to global tariff changes, it serves as a model for other sectors.
The Evolution of the Pharmaceutical Industry
- The domestic pharmaceutical sector has transformed since the TRIPS Agreement in 1995.
- Facing challenges from the product-patent regime, the sector shifted strategies for competitiveness.
- This transition involved significant investments in research and development, leading to innovative novel drug delivery systems.
Key Findings from the Economic Survey
- The industry increased R&D spending dramatically from ₹1,250 million in 1994 to nearly ₹209.8 billion by 2019.
- Pharmaceutical companies expanded into regulated markets, significantly raising DMF filings.
- This diversification mitigated risks associated with tariff changes and improved access to global markets.
The Economic Survey posits that strategic consolidation and market diversification are essential to navigate future challenges. By reinforcing internal capabilities, Indian companies can leverage global opportunities more effectively.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.